Informal Request for ATI Records Previously Released

Organization: Health Canada

Year: 2022

Month: December

Request Number: A-2022-000816

Request Summary: The most current Canadian Risk Management Plan (RMP) or Canadian Addendum to the RMP and Canadian RMP review report for NEUPOGEN by Amgen Canada Inc., Drug Identification Numbers (DINs) 01968017, 02420104, and 02420112.

Disposition: Disclosed in part

Number of pages: 123

Date modified: